Is EGFR really a therapeutic target in head and neck cancers?
Author:
Affiliation:
1. Department of Medical OncologyHCG Cancer CentreBangalore India
2. Department of Head and Neck OncologyHCG Cancer CentreBangalore India
Publisher
Wiley
Subject
Oncology,General Medicine,Surgery
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1002/jso.25387
Reference19 articles.
1. Characterization, quantification, and potential clinical value of the epidermal growth factor receptor in head and neck squamous cell carcinomas
2. Levels of TGF-α and EGFR Protein in Head and Neck Squamous Cell Carcinoma and Patient Survival
3. Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and Neck
4. Platinum-Based Chemotherapy plus Cetuximab in Head and Neck Cancer
5. Open-Label, Uncontrolled, Multicenter Phase II Study to Evaluate the Efficacy and Toxicity of Cetuximab As a Single Agent in Patients With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck Who Failed to Respond to Platinum-Based Therapy
Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Manifestaciones cutáneas asociadas al uso de cetuximab;Piel;2024-05
2. Identification of Genes Involved in EGF-induced Apoptosis Using CRISPR/Cas9 Knockout Screening: Implications for Novel Therapeutic Targets in EGFR-Overexpressing Cancers;Cancer Research and Treatment;2023-07-15
3. A Case of Complete Remission of Nasal Cavity Poorly Differentiated Carcinoma With Targeted Therapy, to Which Surgery and Concurrent Chemoradiotherapy Was Ineffective;Korean Journal of Otorhinolaryngology-Head and Neck Surgery;2023-03-21
4. Escape from Cellular Senescence Is Associated with Chromosomal Instability in Oral Pre-Malignancy;Biology;2023-01-10
5. A review of efficacy and safety of cetuximab and bevacizumab-based monoclonal antibodies in head and neck cancer;Medical Oncology;2022-12-30
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3